Trump admin moves to scrap biologics exclusivity in trade deal—and pharma's not amused

11th December 2019 Uncategorised 0

In a quiet, last-minute deal during North American trade talks, the Trump administration agreed to scrap rules protecting biologic drugs from copycat competition. Instead, the three countries could set their own rules, potentially opening big brands up to earlier-than-expected biosim rivals.

More: Trump admin moves to scrap biologics exclusivity in trade deal—and pharma's not amused
Source: fierce